Diganan cross-linked sodium hyaluronate
丁甘交联玻璃酸钠
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameDiganan cross-linked sodium hyaluronate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2013/10/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Jiashitai Pharmaceutical Biotechnology Co LtdLg Chemical LtdYifan Pharmaceutical Co Ltd
Inactive CompaniesGenzyme Corp
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A